We are live on ! Find out more
AGIO icon

Agios Pharmaceuticals
AGIO

178 hedge funds and large institutions have $2.69B invested in Agios Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 66 increasing their positions, 58 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 22

14% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 58

4% more funds holding

Funds holding: 171 → 178 (+7)

1.21% more ownership

Funds ownership: 95.18% → 96.38% (+1.2%)

13% less capital invested

Capital invested by funds: $3.07B → $2.69B (-$388M)

33% less call options, than puts

Call options by funds: $10.2M | Put options by funds: $15.1M

80% less funds holding in top 10

Funds holding in top 10: 5 → 1 (-4)

Holders
178
Holders Change
+7
Holders Change %
+4.09%
% of All Funds
4.04%
Holding in Top 10
1
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-80%
% of All Funds
0.02%
New
30
Increased
66
Reduced
58
Closed
22
Calls
$10.2M
Puts
$15.1M
Net Calls
-$4.96M
Net Calls Change
-$9.09M

Top Buyers

1
UBS AM
UBS AM
Illinois
+$19.7M
2
PAMU
Pictet Asset Management (UK)
United Kingdom
+$14.7M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$14M
4
PI
Putnam Investments
Massachusetts
+$13.3M
5
First Trust Advisors
First Trust Advisors
Illinois
+$10.7M

Top Sellers

1
Capital International Investors
Capital International Investors
California
-$20.5M
2
CI
Capital International
California
-$13.2M
3
QIM
Quantitative Investment Management
Virginia
-$10.3M
4
Invesco
Invesco
Georgia
-$8.69M
5
CWAM
Columbia Wanger Asset Management
Illinois
-$8.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
STA
151
Summit Trail Advisors
New York
$20K +$17.7K +282 New
AG
152
Advisor Group
Arizona
$17K +$18.9K +300 New
WPA
153
West Paces Advisors
Georgia
$14.6K – – –
FPS
154
Fieldpoint Private Securities
Connecticut
$12K – – –
Envestnet Asset Management
155
Envestnet Asset Management
Illinois
$12K +$1.7K +27 +15%
MFW
156
Mosaic Family Wealth
Missouri
$11K – – –
SWP
157
Stratos Wealth Partners
Ohio
$11K +$12.6K +200 New
Fifth Third Bancorp
158
Fifth Third Bancorp
Ohio
$9K -$33.6K -534 -78%
VNA
159
Valley National Advisers
Pennsylvania
$9K – – –
WTC
160
WhitTier Trust Company
Nevada
$8K – – –
CSS
161
Cubist Systematic Strategies
Connecticut
$6K -$144K -2,291 -96%
US Bancorp
162
US Bancorp
Minnesota
$6K -$1.07K -17 -13%
Bessemer Group
163
Bessemer Group
New Jersey
$6K – – –
RFC
164
Regions Financial Corp
Alabama
$6K +$6.29K +100 New
PHK
165
Point72 Hong Kong
Hong Kong
$5K -$9.56K -152 -63%
SBL
166
Sargent Bickham Lagudis
Colorado
$5K – – –
ASN
167
Advisory Services Network
Georgia
$5K +$3.15K +50 +167%
PNC Financial Services Group
168
PNC Financial Services Group
Pennsylvania
$5K +$3.4K +54 +120%
MOS
169
MGO One Seven
Ohio
$5K +$5.85K +93 New
IWM
170
IHT Wealth Management
Illinois
$4K +$3.77K +60 New
TRCT
171
Tower Research Capital (TRC)
New York
$4K +$4.28K +68 New
Russell Investments Group
172
Russell Investments Group
United Kingdom
$3K -$83K -1,319 -97%
BBHC
173
Brown Brothers Harriman & Co
New York
$3K +$3.33K +53 New
APA
174
American Portfolios Advisors
New York
$2.57K +$2.83K +45 New
TFO
175
Tarbox Family Office
California
$1K – – –
4 5 6
7
8

AGIO Hedge Fund Activity: Q4 2017 in Review

178 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Agios Pharmaceuticals (AGIO) for Q4 2017, worth a combined $2.69B — down 13% from $3.07B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new AGIO positions and 22 closed out — a net gain of 8 holders — while 66 added to existing stakes and 58 trimmed.

The largest buyer was UBS AM, adding an estimated $19.7M. The largest seller was Capital International Investors, cutting an estimated $20.5M.

  • 178 institutional investors held Agios Pharmaceuticals (AGIO) as of Q4 2017, up from 171 in Q3 2017.
  • Funds reported $2.69B of Agios Pharmaceuticals stock for Q4 2017, down 13% quarter-over-quarter.
  • 30 funds opened new Agios Pharmaceuticals positions in Q4 2017 and 22 closed out, a net change of +8 holders.
  • The largest Agios Pharmaceuticals buyer in Q4 2017 was UBS AM, an estimated $19.7M added.
  • The largest Agios Pharmaceuticals seller in Q4 2017 was Capital International Investors, an estimated $20.5M sold.

Based on aggregated 13F filings for Q4 2017.